TORNTPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > torntpharm

Technical Analysis

Technical Strength: 6.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 72.2. According to RSI analysis, torntpharm is overbought. 3.0 TORNTPHARM RSI Chart
MACD (?) MACD: 46.8 and Signal Line: 34.3. According to MACD analysis, torntpharm is technically strong. 8.0 TORNTPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, torntpharm is in a strong uptrend. Major support levels are 1921.875, 1869.406, 1715.54. 10.0 TORNTPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, torntpharm is in a strong uptrend. Major support levels are 1941.291, 1877.543, 1757.471. 10.0 TORNTPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.933. According to bollinger bands, torntpharm is technically strong. 7.0 TORNTPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1926.7519 and 1881.375. Resistance level is 2073.65. 6.5 TORNTPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 47 NA TORNTPHARM Average True Range Chart
Average Directional Index (?) ADX is 34 which means TORNTPHARM is in a trend. NA TORNTPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 24, 2020
Open Price 2029.0
High Price 2062.0
Low Price 2025.0
Close Price 2036.95
Absolute Change 16.45
Percentage Change 0.814%
Weekly Change 1.53%
Monthly Change 9.29%
Yearly Change 7.68%
52-week high 2073.65
52-week low 1452.0
Corporate Actions
ExDate Purpose
February 03, 2020 INTERIM DIVIDEND
June 13, 2019 DIV-RS 4 PER SH
February 06, 2019 INT DIV - RS 13 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.407
Confidence in Beta0.461%
Market Capital Rs. 34469.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 January 2020: Deliverable Quantity:6.69e+04 NA TORNTPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 January 2020: Daily Volatility:0.2656 NA TORNTPHARM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 January 2020: PCR_OI:0.331 PCR:0.0262 NA TORNTPHARM PCR Chart
Option Pain (?) 24 January 2020: Max Pain:1940.0 NA TORNTPHARM Option Pain Chart
Premium (?) 24 January 2020 Premium: 3.55 Futures OI:339000.0 NA TORNTPHARM Premium Chart
Option_MAX_OI (?) 24 January 2020: Price:2036.95 Put with maximum OI:1760.0 Call with maximum OI:2140.0 NA TORNTPHARM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 30, 2020 2040.5 339000.0 1307.0 1307.0 2036.95
February 27, 2020 2036.8 42500.0 119.0 119.0 2036.95
March 26, 2020 2040.75 1500.0 1.0 1.0 2036.95

Announcements

August 13, 2018 Shareholders meeting Revised Shareholder Meeting / Postal Ballot-Scrutinizer's Report
April 13, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Samir Mehta has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 16, 2020 January 27, 2020 Financial Results/Dividend/Fund Raising To consider and approve the financial results for the period ended December 31, 2019, dividend and Fund Raising
October 14, 2019 October 23, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
See all Board Meetings

TORNTPHARM is part of...

Index Weightage
NFTYMCAP50 NA

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play